Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer
Authors:
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 12 (1) , 57-63
Abstract
No abstract availableKeywords
Funding Information
- biostatistics epidemiology public health and innovation in methodology department
This publication has 30 references indexed in Scilit:
- Polypharmacy and potentially inappropriate medication use in geriatric oncologyJournal of Geriatric Oncology, 2016
- International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With CancerJournal of Clinical Oncology, 2014
- Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancerJournal of Geriatric Oncology, 2012
- The Role of the Pharmacist in Optimizing Pharmacotherapy in Older PeopleDrugs & Aging, 2012
- Polypharmacy in elderly patients with cancer: clinical implications and managementThe Lancet Oncology, 2011
- Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project.Journal of Clinical Oncology, 2011
- Comorbidity and polypharmacy in elderly cancer patients: The significance on treatment outcome and toleranceJournal of Geriatric Oncology, 2010
- Comprehensive Geriatric Assessment for Older Patients With CancerJournal of Clinical Oncology, 2007
- Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect managementJournal of Clinical Pharmacy and Therapeutics, 2007
- Reduction of Polypharmacy in the ElderlyDrugs & Aging, 2003